(Q36451425)

14 August 2017

1 reference

title

Advances in the treatment of testicular cancer. (English)

1 reference

14 August 2017

Hans-Georg Kopp

1

1 reference

14 August 2017

Markus Kuczyk

2

1 reference

14 August 2017

Johannes Classen

3

1 reference

14 August 2017

Arnulf Stenzl

4

1 reference

14 August 2017

Lothar Kanz

5

1 reference

14 August 2017

Frank Mayer

6

1 reference

14 August 2017

Michael Bamberg

7

1 reference

14 August 2017

Jörg Thomas Hartmann

8

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

66

1 reference

14 August 2017

641-659

1 reference

14 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666050-00005

14 August 2017

0 references

cites work

Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working

1 reference

12 December 2020

Long-term renal function after treatment for malignant germ-cell tumours

1 reference

12 December 2020

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

1 reference

12 December 2020

Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial

1 reference

12 December 2020

Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors

1 reference

12 December 2020

Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone

1 reference

12 December 2020

Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience

1 reference

12 December 2020

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

12 December 2020

A cytogenetic classification of germ cell tumors, and its biological relevance

1 reference

12 December 2020

Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

1 reference

12 December 2020

New insights into the pathology and molecular biology of human germ cell tumors.

1 reference

12 December 2020

Testicular function following chemo-radiotherapy

1 reference

12 December 2020

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours

1 reference

12 December 2020

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C

1 reference

12 December 2020

Radiotherapy for stage II testicular seminoma

1 reference

12 December 2020

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

1 reference

12 December 2020

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

1 reference

12 December 2020

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

1 reference

12 December 2020

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol

1 reference

12 December 2020

Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors

1 reference

12 December 2020

Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors

1 reference

12 December 2020

Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study

1 reference

12 December 2020

Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20

1 reference

12 December 2020

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group

1 reference

12 December 2020

Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group

1 reference

12 December 2020

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial

1 reference

12 December 2020

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

1 reference

12 December 2020

Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer

1 reference

12 December 2020

Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor

1 reference

12 December 2020

Surgery for a post-chemotherapy residual mass in seminoma

1 reference

12 December 2020

Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients

1 reference

12 December 2020

The activity of single-agent carboplatin in advanced seminoma

1 reference

12 December 2020

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

1 reference

12 December 2020

Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.

1 reference

12 December 2020

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Ca

1 reference

12 December 2020

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

12 December 2020

Seminoma of the testis: a 22-year experience with radiation therapy

1 reference

12 December 2020

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17).

1 reference

12 December 2020

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

1 reference

12 December 2020

Long-term somatic side-effects and morbidity in testicular cancer patients

1 reference

12 December 2020

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party

1 reference

12 December 2020

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer

1 reference

12 December 2020

A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study

1 reference

12 December 2020

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors

1 reference

12 December 2020

Prognostic Factors for Relapse in Stage I Testicular Seminoma Treated With Surveillance

1 reference

12 December 2020

First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial

1 reference

12 December 2020

Complications of primary retroperitoneal lymph node dissection

1 reference

12 December 2020

RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment

1 reference

12 December 2020

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

1 reference

12 December 2020

Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis

1 reference

12 December 2020

Gonadal dysfunction in patients treated for metastatic germ-cell tumors

1 reference

12 December 2020

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report

1 reference

12 December 2020

Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

1 reference

12 December 2020

Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer

1 reference

12 December 2020

Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.

1 reference

12 December 2020

High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis

1 reference

12 December 2020

A phase II trial of paclitaxel in refractory germ cell tumors

1 reference

12 December 2020

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

1 reference

12 December 2020

Adjuvant chemotherapy for stage II nonseminomatous germ cell cancer of the testis

1 reference

12 December 2020

Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients

1 reference

12 December 2020

Prognostic factors for favorable outcome in disseminated germ cell tumors

1 reference

12 December 2020

Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours

1 reference

12 December 2020

Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors

1 reference

12 December 2020

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

1 reference

12 December 2020

Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

1 reference

12 December 2020

Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer

1 reference

12 December 2020

Endocrinological late effects after chemotherapy for testicular cancer

1 reference

12 December 2020

Salvage chemotherapy in relapsed germ cell tumors

1 reference

12 December 2020

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

1 reference

12 December 2020

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

12 December 2020

Fertility after chemotherapy for testicular germ cell cancer

1 reference

12 December 2020

The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).

1 reference

12 December 2020

Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

1 reference

12 December 2020

Stage I testicular seminoma: results of adjuvant irradiation and surveillance

1 reference

12 December 2020

Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial

1 reference

12 December 2020

Evaluation of long-term toxicity after chemotherapy for testicular cancer

1 reference

12 December 2020

Multimodality treatment of patients with liver metastases from germ cell tumors: the role of surgery

1 reference

12 December 2020

Salvage chemotherapy for recurrent germ cell cancer

1 reference

12 December 2020

Fertility after chemotherapy for testicular germ cell cancers

1 reference

12 December 2020

Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

12 December 2020

Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer

1 reference

12 December 2020

Cisplatin combination chemotherapy in advanced seminoma

1 reference

12 December 2020

Secondary neoplasms following treatment of malignant germ cell tumors

1 reference

12 December 2020

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area

1 reference

12 December 2020

Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors

1 reference

12 December 2020

Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

1 reference

12 December 2020

Platinum organ toxicity and possible prevention in patients with testicular cancer

1 reference

12 December 2020

Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment

1 reference

12 December 2020

First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.

1 reference

12 December 2020

Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors

1 reference

12 December 2020

Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy

1 reference

12 December 2020

Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer

1 reference

12 December 2020

Results of radiotherapy for stage II testicular seminoma

1 reference

12 December 2020

Curing metastatic cancer: lessons from testicular germ-cell tumours

1 reference

12 December 2020

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

12 December 2020

Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group

1 reference

12 December 2020

Long-term effects on sexual function and fertility after treatment of testicular cancer

1 reference

12 December 2020

Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer.

1 reference

12 December 2020

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourin

1 reference

12 December 2020

Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?

1 reference

12 December 2020

Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma

1 reference

12 December 2020

Late relapse of clinical stage I testicular cancer

1 reference

12 December 2020

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Ca

1 reference

12 December 2020

A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial

1 reference

12 December 2020

Testicular cancer: an oncological success story

1 reference

12 December 2020

Residual mass following chemotherapy of seminoma

1 reference

12 December 2020

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study

1 reference

12 December 2020

The treatment of advanced metastatic seminoma: experience in 55 cases

1 reference

12 December 2020

Phase II trial of gemcitabine in refractory germ cell tumors

1 reference

12 December 2020

Long-term effects of chemotherapy in patients with testicular cancer

1 reference

12 December 2020

Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis

1 reference

12 December 2020

Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term followup in 52 patients

1 reference

12 December 2020

Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors

1 reference

12 December 2020

Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.

1 reference

12 December 2020

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

1 reference

12 December 2020

Testicular germ-cell tumours in a broader perspective.

1 reference

12 December 2020

Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse

1 reference

12 December 2020

Long-term complications of cisplatin-based chemotherapy for testis cancer.

1 reference

12 December 2020

The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours.

1 reference

12 December 2020

Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis

1 reference

12 December 2020

Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts

1 reference

12 December 2020

Hepatic resection of metastatic testicular carcinoma: a further update

1 reference

12 December 2020

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party

1 reference

12 December 2020

Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials

1 reference

12 December 2020

Paclitaxel in salvage therapy for germ cell tumors

1 reference

12 December 2020

Treatment of testicular cancer and the development of secondary malignancies

1 reference

12 December 2020

Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor

1 reference

12 December 2020

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

1 reference

12 December 2020

No Adjuvant Chemotherapy in Selected Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumors of the Testis

1 reference

12 December 2020

Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer

1 reference

12 December 2020

Toxicity of platinum compounds

1 reference

12 December 2020

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Resear

1 reference

12 December 2020

Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience

1 reference

12 December 2020

Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial.

1 reference

12 December 2020

Treatment outcome of patients with brain metastases from malignant germ cell tumors.

1 reference

12 December 2020

Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols

1 reference

12 December 2020

Klinefelter's syndrome associated with mediastinal germ cell neoplasms.

1 reference

12 December 2020

Surgical treatment of stage-I non-seminomatous germ cell testis tumor. Final results of a prospective multicenter trial 1982-1987. Testicular Tumor Study Group.

1 reference

12 December 2020

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).

1 reference

12 December 2020

Oxaliplatin in non-seminomatous germ-cell tumors

1 reference

12 December 2020

Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation

1 reference

12 December 2020

Oral etoposide in germ cell tumours

1 reference

12 December 2020

Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer

1 reference

12 December 2020

Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin

1 reference

12 December 2020

Single-agent carboplatinum for advanced seminoma. A phase II study

1 reference

12 December 2020

Multivariate analysis of prognostic variables in patients with metastatic testicular cancer.

1 reference

12 December 2020

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer

1 reference

12 December 2020

Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study

1 reference

12 December 2020

Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group

1 reference

12 December 2020

Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial

1 reference

12 December 2020

10.2165/00003495-200666050-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference